The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.

Slides:

Advertisements

Similar presentations

UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.

Advertisements

CDCs 21 Goals. CDC Strategic Imperatives 1. Health impact focus: Align CDCs people, strategies, goals, investments & performance to maximize our impact.

The NVPO Unmet Needs Program: FY 2006 Update Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting, June 2006.

2014 UPDATES FROM THE CDC’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) William Schaffner, MD Professor of Preventive Medicine and Infectious Diseases.

Health and Sustainable Development: HIV in the Post Development Agenda Steve Kraus Director, Regional Support Team for Asia and the Pacific UNAIDS.

Long-Term Services and Supports and the National Plan To Address Alzheimer’s Disease October 30th, 2014 Rohini Khillan Office of Disability, Aging, and.

Review of The CDC’s Smallpox Vaccination Program Implementation Kristine Gebbie, R.N., Dr.P.H. NVAC June 2003.

1 Prioritization of Vaccine Targets for Development CDR Angela Shen National Vaccine Program Office June 2, 2010 NVAC.

The Work of WHO in the South-East Asia Region The Work of WHO in the South-East Asia Region Biennial Report of the Regional Director 1 January

Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.

1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.

J. Nadine Gracia, MD, MSCE Deputy Assistant Secretary for Minority Health (Acting) Office of Minority Health U.S. Department of Health and Human Services.

Citizen Voices on the National Vaccine Plan Michelle Schaur, MPH Oak Ridge Institute for Science and Education.

Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.

A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.

Outcomes of Public Health

Maryland’s Money Follows the Person Rebalancing Demonstration Maryland Medicaid Advisory Committee Stacey Davis March 26, 2007.

Global Response to HIV/AIDS Nigerian Nurses Association of USA June 30, 2006 Carolyn M Hall, MSN/MPH, ACRN Global HIV/AIDS Program U.S. Department of Health.

Overview. A brief history…. World Economic Forum, January 2010 – Bill and Melinda Gates highlight that 8-10 million deaths can be prevented in the next.

Presentation to Consortium of Care MARYLAND DENTAL ACTION COALITION April 27, 2011.

Adult Immunization at CDC Gina T. Mootrey, DO, MPH NVAC, October 22, 2007.

THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.

CDC’s Advisory Committee on Immunization Practices (ACIP) CDC’s Advisory Committee on Immunization Practices (ACIP) How is Vaccine Policy Made? William.

Bell - ringer Please have out name card in front of you With your “table” group or seat partner, answer this question: What is public health? Be prepared.

IOM Report on Financing Vaccines in the 21 st Century: National Vaccine Advisory Committee Follow-up Alan R. Hinman, MD, MPH Chair, NVAC Workgroup on IOM.

Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)

Update of The National Vaccine Plan Bruce G. Gellin, M.D., M.P.H., and Raymond A. Strikas, MD National Vaccine Program Office Department of Health and.

1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.

America Responds: An HHS 2009-H1N1 Retrospective to Advance All Hazards Preparedness Discussion with the National Vaccine Advisory Committee June 3, 2010.

Influenza Vaccination Update for Jeanne M. Santoli, MD, MPH Deputy Director, Immunization Services Division National Center for Immunization and.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair June 2, 2010.

Millennium Development Goals Carla AbouZahr Coordinator, Statistics, Monitoring and Analysis Department of Health Statistics and Informatics World Health.

(Slide 1 of 22) Response to the National Vaccine Advisory Committee Recommendations on the Immunization Safety Office Scientific Agenda Frank DeStefano,

Strategies to Consider to Improve ACCV Effectiveness Presentation to ACCV Vito Caserta M.D., M.P.H. Vincent Matanoski, J.D. December 5,

COMMUNITY HEALTH IMPROVEMENT PLAN (CHIP) ANNUAL UPDATE REPORT Health Care Access Committee September 28, 2015.

Component 1: Introduction to Health Care and Public Health in the U.S. 1.1: Unit 2: Health Care Settings 1.2 a: Overview and the Organization of Federal.

NVAC H1N1 Vaccine Safety Risk Assessment Working Group (VSRAWG) Update NVAC Meeting June 2, 2010 Marie McCormick, M.D., Sc.D. Sumner and Esther Feldberg.

Joint Meeting of the Coverage and Future Vaccines Subcommittees October 5, 2004.

HHS Secretary’s Advisory Committee on Blood Safety and Availability Summary for FDA’s BPAC July 2010 Jerry A. Holmberg, Ph.D. Senior Advisor for Blood.

ASTMH 2015 Capitol Hill Day Asks. ASTMH “Asks” Provide robust funding for NIH, CDC, USAID and DoD global health and infectious disease programs for fiscal.

Non-institutionalized adults vaccinated annually against influenza and ever vaccinated against pneumococcal disease. Healthy Kansans 2010 Steering Committee.

Public Health Options for Implementing Vaccine Recommendations: A Framework for State Decision Making Donald Williamson, M.D. National Vaccine Advisory.

Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.

Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.

National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.

The National Vaccine Plan Update: Recent Activities and Next Steps Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human.

THE NATIONAL VACCINE PROGRAM OFFICE NATIONAL ADULT IMMUNIZATION PLAN OVERVIEW.

NVAC Influenza Working Group: Preliminary Report Charles Helms, M.D., Ph.D. June 1, 2004.

NVAC Vaccine Safety Risk Assessment Working Group (VSRAWG) Update NVAC Meeting February 3, 2010 Marie McCormick, M.D., Sc.D. Sumner and Esther Feldberg.

The NVPO Unmet Needs Program: Looking Back and Moving Forward Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting,

H1N1 Vaccine Safety Subgroup: Draft Recommendations to NVAC NVAC Teleconference July 27, 2009 Daniel Salmon Vaccine Safety Specialist National Vaccine.

Wisconsin Department of Health Services CDC and HRSA released guidance on June 19, 2015 Guidance for health departments and planning groups Development.

Unit 4 – Risk Reduction Program Planning. Unit 4 - Seminar Topics  Collaborating with stakeholders in addressing risk reduction  Identifying and prioritizing.

Board of Health Proposed 2011 Public Health Budget October 29, 2010 Dr. David Fleming Director and Health Officer.

Social Protection Global Technical Team Retreat,

National Immunization Conference April 19, 2010

Update: The Global Fund Activities in Thailand

Stakeholder Consultation

U.S. Global Health Funding, By Sector, FY 2006-FY 2016 Request

The State of Pneumococcal Disease Prevention

Distribution of U.S. Global Health Funding, By Sector, FY 2006-FY 2018 Request NOTES: Represents total known funding (base and supplemental) provided.

U.S. Global Health Funding, By Sector, FY 2018 Request

U.S. Global Health Funding, By Sector, FY 2019 Request

U.S. Global Health Funding, By Sector, FY FY 2018 Request

U.S. Global Health Funding: President’s Emergency Plan for AIDS Relief (PEPFAR), FY 2004-FY 2017 Request In Millions NOTES: PEPFAR was created in 2003.

Distribution of U.S. Global Health Funding, By Sector, FY 2006-FY 2018 Request NOTES: Represents total known funding provided through the State Department,

Share of U.S. Global Health Funding, By Sector, FY 2006-FY 2018 Request

Sustaining Primary Care-Public Health Partnerships for Engagement in Care – The Partnerships for Care Demonstration Project Sue Lin, PhD, MS Director,

Updating the National Vaccine Plan: A roadmap for the next decade A National, not Federal, Plan December 11, 2009.

March 8, 2006 New ACIP Hepatitis B Recommendations

Presentation transcript:

The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services

Planning Process Summary Process to date –March 20 and June 5, 2007 interagency meetings –Discussions with Assistant Secretary for Health One-on-one discussions with agencies, Departments: CDC, FDA, NIH, HRSA, AHRQ, ASPR, USAID, DoD Priorities’ development by agencies, Departments

Four Categories (1994 Plan’s Goals) Develop new and improved vaccines Ensure optimal safety and effectiveness of vaccines and immunization Better educate the public and members of the health professions on the benefits and risks of immunizations Achieve better use of existing vaccines to prevent disease, disability, and death

Top Ten Priority Areas (really 11) 1.Vaccine research and development: Enhance 2.Adult Immunization: Improve immunization rates for vaccines recommended for widespread use among adults to achieve coverage targets 3.Adolescent Immunization: Achieve 90% coverage for ACIP recommended vaccines 4.Barriers to vaccination: Reduce or eliminate financial barriers to access for recommended vaccines for all populations 5.Childhood vaccination: Maintain high coverage 6.New Vaccines: Develop, such as 1.HIV 2.TB 3.Malaria

Top Ten Priority Areas (really 11) - continued 7. Vaccine Supply: Enhance security 8. Vaccine Safety: Enhance current infrastructure to better monitor adverse events and determine risk factors and mechanisms for adverse events 9. Compensation: Assure the National Vaccine Injury Program continues to compensate persons truly injured by vaccines 10. Global Health: Advance global disease reduction and eradication goals 11. Surveillance: Assure systems are in place to adequately monitor the epidemiology of vaccine-preventable diseases and immunization coverage

Priorities Received from many, but not all, agencies and offices. Limited prioritization within lists offered Few milestones and dates for achievement listed Differences of emphasis to be resolved

Our Tasks for the Priorities Review categories, areas, issues in particular –Are all listed appropriate? –What is missing? Propose actions as appropriate (to be completed by lead, contributing agencies) Review proposed lead and contributing agencies To follow: –Prioritization within areas by lead agencies – milestones –NVAC review, beginning with Vaccine Supply and Development subcommittee today

Stakeholder Involvement Approach Complete priorities’ table Review with National Vaccine Advisory Committee Engage other expert stakeholders through Institute of Medicine expert committee (discussion to follow) Engage broader groups of stakeholders, including the general public –Focus groups’ trial October 30, 2007 –“Deliberation Day” town-hall style meeting(s) to follow